|
GNH KOREA |
¿Ü±¹°è Á¦¾àȸ»ç RA Manager (Â÷.ºÎÀå±Þ)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
8³â¡è |
ä¿ë½Ã |
03.19 |
|
|
GNH KOREA |
¿Ü±¹°è Á¦¾àȸ»ç RA Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
03.19 |
|
|
Ä¿¸®¾îÄɾî |
±×·ì»ç ¹ÙÀÌ¿ÀÀǾàÇ° Çã°¡ ´ã´ç
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
05.02 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀåÁ¦¾à»ç °³¹ßºÎ °£ºÎ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.09 |
|
|
Ä¿¸®¾îÄɾî |
±Û·Î¹ú ÀÇ·áÀåºñ±â¾÷ FDA ÀÎÇã°¡
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
05.10 |
|
|
»ç¶÷ÀÎHR |
±Û·Î¹ú¹ÙÀÌ¿À±â¾÷ CMC(Chemistry, Manufacture & Control)
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
»ó½Ãä¿ë |
05.21 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå´ë±â¾÷ BD °æ·ÂÀÚ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.10 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
´ë±â¾÷ °³¹ßÆÀÀå ¸ðÁýÇÕ´Ï´Ù.
°æ±â ¼ö¿ø½Ã ±Ç¼±±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
07.03 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
Regulatory Affairs-Health Care MNC
¼¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
07.03 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
Glabal BD Manager - ÀÓ»óÀü¹®±â¾÷
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
9³â¡è |
ä¿ë½Ã |
07.03 |
|
|
ºñÀü¼Ä¡ |
ÄÚ½º´Ú µî·Ï ±Û·Î¹ú ¹ÙÀÌ¿À Á¦¾à»ç ÀÓ»ó°³¹ßÆÀÀå ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
8³â¡è |
ä¿ë½Ã |
11.14 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
RA Specialist/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
03.07 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹Àû Á¦¾àȸ»ç _ External Affairs Specialist
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
02.13 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
RA Specialist/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
02.07 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
°³¹ß(Licensing-in)´ã´çÀÚ/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
12.21 |
|